2-[(3S,6S,9S,15S,18S,21S,24S,27S,30S)-15,18-dibutan-2-yl-6-[(4-methoxy phenyl)methyl]-3,10,16,19,22,28-hexamethyl-2,5,8,11,14,17,20,23,26,29- decaoxo-9,24,27-tripropan-2-yl-4-oxa-1,7,10,13,16,19,22,25,28-nonazabi cyclo[28.4.0]tetratriacont-21-yl]acetic acid

2-[(3S,6S,9S,15S,18S,21S,24S,27S,30S)-15,18-dibutan-2-yl-6-[(4-methoxy phenyl)methyl]-3,10,16,19,22,28-hexamethyl-2,5,8,11,14,17,20,23,26,29- decaoxo-9,24,27-tripropan-2-yl-4-oxa-1,7,10,13,16,19,22,25,28-nonazabi cyclo[28.4.0]tetratriacont-21-yl]acetic acid Struktur
159404-79-2
CAS-Nr.
159404-79-2
Englisch Name:
2-[(3S,6S,9S,15S,18S,21S,24S,27S,30S)-15,18-dibutan-2-yl-6-[(4-methoxy phenyl)methyl]-3,10,16,19,22,28-hexamethyl-2,5,8,11,14,17,20,23,26,29- decaoxo-9,24,27-tripropan-2-yl-4-oxa-1,7,10,13,16,19,22,25,28-nonazabi cyclo[28.4.0]tetratriacont-21-yl]acetic acid
Synonyma:
L-Tyrosine, N-[N-[N-[N-[N-[N-[N-[N-[[1-(2-hydroxy-1-oxopropyl)-L-2-piperidinyl]carbonyl]-N-methyl-L-valyl]-L-valyl]-N-methyl-L-α-aspartyl]-N-methyl-L-isoleucyl]-N-methyl-L-isoleucyl]glycyl]-N-methyl-L-valyl]-O-methyl-, δ1-lactone, (S)- (9CI);2-[(3S,6S,9S,15S,18S,21S,24S,27S,30S)-15,18-dibutan-2-yl-6-[(4-methoxy phenyl)methyl]-3,10,16,19,22,28-hexamethyl-2,5,8,11,14,17,20,23,26,29- decaoxo-9,24,27-tripropan-2-yl-4-oxa-1,7,10,13,16,19,22,25,28-nonazabi cyclo[28.4.0]tetratriacont-21-yl]acetic acid
CBNumber:
CB61256345
Summenformel:
C57H91N9O14
Molgewicht:
1126.38
MOL-Datei:
159404-79-2.mol

2-[(3S,6S,9S,15S,18S,21S,24S,27S,30S)-15,18-dibutan-2-yl-6-[(4-methoxy phenyl)methyl]-3,10,16,19,22,28-hexamethyl-2,5,8,11,14,17,20,23,26,29- decaoxo-9,24,27-tripropan-2-yl-4-oxa-1,7,10,13,16,19,22,25,28-nonazabi cyclo[28.4.0]tetratriacont-21-yl]acetic acid Eigenschaften

Siedepunkt:
1291.1±65.0 °C(Predicted)
Dichte
1.23±0.1 g/cm3(Predicted)
pka
4.00±0.10(Predicted)

Sicherheit

2-[(3S,6S,9S,15S,18S,21S,24S,27S,30S)-15,18-dibutan-2-yl-6-[(4-methoxy phenyl)methyl]-3,10,16,19,22,28-hexamethyl-2,5,8,11,14,17,20,23,26,29- decaoxo-9,24,27-tripropan-2-yl-4-oxa-1,7,10,13,16,19,22,25,28-nonazabi cyclo[28.4.0]tetratriacont-21-yl]acetic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

2-[(3S,6S,9S,15S,18S,21S,24S,27S,30S)-15,18-dibutan-2-yl-6-[(4-methoxy phenyl)methyl]-3,10,16,19,22,28-hexamethyl-2,5,8,11,14,17,20,23,26,29- decaoxo-9,24,27-tripropan-2-yl-4-oxa-1,7,10,13,16,19,22,25,28-nonazabi cyclo[28.4.0]tetratriacont-21-yl]acetic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


2-[(3S,6S,9S,15S,18S,21S,24S,27S,30S)-15,18-dibutan-2-yl-6-[(4-methoxy phenyl)methyl]-3,10,16,19,22,28-hexamethyl-2,5,8,11,14,17,20,23,26,29- decaoxo-9,24,27-tripropan-2-yl-4-oxa-1,7,10,13,16,19,22,25,28-nonazabi cyclo[28.4.0]tetratriacont-21-yl]acetic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
HONEST JOY HOLDINGS LIMITED --
sales@honestjoy.cn United States 6702 54

  • 2-[(3S,6S,9S,15S,18S,21S,24S,27S,30S)-15,18-dibutan-2-yl-6-[(4-methoxy phenyl)methyl]-3,10,16,19,22,28-hexamethyl-2,5,8,11,14,17,20,23,26,29- decaoxo-9,24,27-tripropan-2-yl-4-oxa-1,7,10,13,16,19,22,25,28-nonazabi cyclo[28.4.0]tetratriacont-21-yl]acetic acid
  • L-Tyrosine, N-[N-[N-[N-[N-[N-[N-[N-[[1-(2-hydroxy-1-oxopropyl)-L-2-piperidinyl]carbonyl]-N-methyl-L-valyl]-L-valyl]-N-methyl-L-α-aspartyl]-N-methyl-L-isoleucyl]-N-methyl-L-isoleucyl]glycyl]-N-methyl-L-valyl]-O-methyl-, δ1-lactone, (S)- (9CI)
  • 159404-79-2
  • C57H91N9O14
Copyright 2019 © ChemicalBook. All rights reserved